Bafna Pharma stock rallies after MHRA renews factory approval

The pharma company received renewal certificate from UK MHRA, as per BSE filing.

May 28, 2018 11:05 IST India Infoline News Service

Stock Market Up
Bafna Pharma stock rallied over 5% on the BSE. The company informed exchanges that pursuant to the audit conducted by Medicines and Healthcare Products Regulatory Agency (MHRA), the facility has got renewal approval as per the guidelines of European Good Manufacturing Practices (EUGMP).

The stock is currently trading at Rs24.65 up by Rs1.15 or 4.89% from its previous closing of Rs23.50 on the BSE.

The scrip opened at Rs24.65 and has touched a high and low of Rs24.65 and Rs24.65 respectively.

Related Story